• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Time to Read the Reports

I found some time to focus on the growing stack of 13HF filings that have been dribbling in.
By TIM MELVIN Feb 13, 2012 | 01:30 PM EST
Stocks quotes in this article: ITT, XLS, XYL, PDLI, BBEP, NWS, NG, ANV, TRGT, TROX

It was an interesting weekend to say the least. We were treated to pictures of Greeks voting and burning all weekend. There was Iranian saber rattling, Israeli embassy bombings and the continuing saga that is the GOP primaries. New York was Lintensely focusing on the Knicks for the first time since the season started, Kentucky kept rolling and Maryland still could not find a way to beat Duke.

It was a dreary weather weekend, so I downloaded some Michael Haskins novel (a new find of enjoyable reading material similar to Randy Wayne White) and spent the weekend in search of the perfect bonding experience with the couch. In the midst of all this I found some time to focus on the growing stack of 13HF filings that have been dribbling in over the last week. The deadline is Wednesday, but this quarter we have seen even more early filers than usual. One suspects even big-time money managers need to plan a decent Valentine's event and being late at the office getting the 13HF filing done is just not going to fly.

As I have for the past few quarters, I went to the filing of Michael Price as soon as it hit the tape again this quarter. Price has purchased some community bank stocks in the past year that have done extraordinarily well so I was hopeful of stealing yet another Trade of the Decade idea from the legendary investor. Unfortunately, he did not buy any banks this past quarter. But there were some interesting ideas. Price has been buying the spin-off stocks from the ITT (ITT) breakup and it looks like there is some value in these names. I am particularly attracted to Excelis (XLS), the defense communications and technology company. Defense stocks have been weak, but the company makes surveillance and reconnaissance equipment as well as command and control communication and cyber security systems. All of that will remain in demand by military and other government agencies in spite of defense cuts.

Xylem (XYL) is another ITT spinoff company that could attract a lot of attention in the years ahead. The global water treatment and test company should do well as the world's demand for water continues to grow and pressure fresh water supplies. Mario Gabelli suggested this stock in the Barron's roundtable this year and pointed out that Xylem would probably be attractive to a larger company. The stock has moved up since the spin off as water stocks have been hot, but it belongs on your research and potential Buy list. Having Mario Gabelli and Michael Price both buying a stock suggest a huge future for the company and the stock price.

The filing form Seth Klarman is always mandatory reading around Chez Melvin. I noted with some interest that he sold his entire stake in PDL Biopharma (PDLI), a  stock I won that has done very well for me in the past year. I never blindly follow anybody. but I do acknowledge that a whole lot of people are a whole lot smarter than me. Klarman is at the top of that list. I will sit down and review my reasons for owning later today. The fund also exited its stake in Breitburn Energy (BBEP), a stock that treated us very well before I sold it in early 2011. He also reduced his stake in News Corp. (NWS) by more than 25% in the quarter.

Klarman also increased his funds position in gold stocks buying more shares of both Novagold Resources (NG) and Allied Nevada (ANV). His new purchases in the quarter included another small biotech company, Targacept (TRGT). Baupost bought 6 million shares of the company, which is almost 17% of the company. Targacept had disappointing results from a trial for a new depression drug last year and the shares have plummeted since. I have little or no understanding of biotech, but will be farming this one out to some associated with deeper knowledge than I. I will report back their conclusions on this stock.

The other new position in Klarman's fund is Tronox (TROX), a company that will have me digging though filings most of the day. At first glance the stock doesn't appear overly cheap, but the business is fascinating. The titanium oxide manufacturer recently merged with a South African company that mines the feedstock materials for titanium dioxide making the company an integrated producer of the pigment material. The company emerged from bankruptcy last year and not only has a stronger balance sheet, but roughly $30 a share in tax loss carry forwards. Given the wide range of uses for titanium dioxide pigment products the company will do very well in an economic recovery is worthy of deeper research.

I have a stock of these reports left to read and more coming in over the next few days. I will report back any additional interesting ideas that are uncovered.

_______


Editor's Links

More investment strategies:

  • What to Own and How Much
  • Weighing Productive Assets Against Gold
  • Attracting Buying Interest (ETF Profits)
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, the author was long PDLI.

TAGS: Investing | U.S. Equity | Stocks

More from Stocks

Don't Shout 'V' for Victory, Yet

James "Rev Shark" DePorre
Jun 27, 2022 4:22 PM EDT

Even after last week's move higher and Monday's narrow range of movement, we can say it's going to be difficult to produce a 'V'-shaped setup like we had at the pandemic low in 2020.

Let's See If Vertex Pharmaceuticals Can Push Higher on the Charts

Bruce Kamich
Jun 27, 2022 3:03 PM EDT

Here's what traders should do.

LyondellBasell Could Hold Temporarily Before Renewed Declines

Bruce Kamich
Jun 27, 2022 2:22 PM EDT

Let's take a look.

Kass: Why Markets Could Make a Yankees-Like Comeback

Doug Kass
Jun 27, 2022 2:00 PM EDT

I remain uncharacteristically bullish. Here's why.

If You Buy Now in This Bear-Bull Battle, You May Be Paying Later

Bob Lang
Jun 27, 2022 1:00 PM EDT

You really want to snag a bargain -- and bank a win -- right now. Here's a better strategy.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login